uracil has been researched along with Cancer of Duodenum in 4 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Excerpt | Relevance | Reference |
---|---|---|
" If an appropriate DIF product is selected and its dosage set based on the patient's urinary uracil value, the occurrence of side effects would be reduced." | 1.35 | [Significance of urinary uracil measurement following administration of DPD inhibitory fluoropyrimidine(DIF)products]. ( Akiyama, I; Fujita, Y; Hasegawa, K; Horiuchi, T; Miyabe, T; Nakajima, Y; Shono, Y; Tabuse, K; Uchida, K, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mikami, R | 1 |
Nishihara, K | 1 |
Matsunaga, H | 1 |
Abe, Y | 1 |
Mitsuyama, S | 1 |
Nasu, T | 1 |
Yamamoto, I | 1 |
Toyoshima, S | 1 |
Motooka, M | 1 |
Horiuchi, T | 1 |
Shono, Y | 1 |
Miyabe, T | 1 |
Nakajima, Y | 1 |
Akiyama, I | 1 |
Uchida, K | 1 |
Fujita, Y | 1 |
Hasegawa, K | 1 |
Tabuse, K | 1 |
Soma, I | 1 |
Hasuike, Y | 1 |
Hayashi, N | 1 |
Fukuchi, N | 1 |
Izawa, H | 1 |
Yoshida, T | 1 |
Ebisui, C | 1 |
Sakita, I | 1 |
Fujimoto, T | 1 |
Koshino, T | 1 |
Izumiyama, K | 1 |
Ohkusa, T | 1 |
Ohtomo, K | 1 |
Yamamoto, N | 1 |
Fujimoto, H | 1 |
4 other studies available for uracil and Cancer of Duodenum
Article | Year |
---|---|
[A case of long survival with unresectable duodenal papilla cancer treated with oral chemotherapy using combination UFT and cyclophosphamide].
Topics: Adenoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tum | 2008 |
[Significance of urinary uracil measurement following administration of DPD inhibitory fluoropyrimidine(DIF)products].
Topics: Adult; Aged; Antineoplastic Agents; Dihydrouracil Dehydrogenase (NADP); Duodenal Neoplasms; Enzyme I | 2009 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined | 2004 |
Primary adenocarcinoma of duodenal bulb benefitted by chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Duodenal Neoplasms; Humans; Liver Ne | 1991 |